## **Core Concept**
Listeria monocytogenes is a gram-positive bacterium that can cause meningitis, particularly in immunocompromised individuals, pregnant women, and neonates. The management of Listeria infections requires specific antibiotic therapy due to its unique resistance pattern. Penicillin is a first-line treatment for Listeria infections, but alternatives are needed for patients with penicillin allergy.

## **Why the Correct Answer is Right**
The correct answer, **D. Trimethoprim-sulfamethoxazole (TMP-SMX)**, is a suitable alternative for patients with Listeria infections who are allergic to penicillin. TMP-SMX has broad-spectrum activity, including against Listeria monocytogenes. It acts by inhibiting dihydrofolate reductase and folic acid synthesis in bacteria, which is bactericidal against Listeria. This combination is effective and often used in patients who cannot receive penicillin or ampicillin due to allergy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although effective against a wide range of bacteria, it is not the preferred choice for Listeria monocytogenes.
- **Option B:** This is incorrect as it is not typically used for Listeria infections and not suitable for patients with penicillin allergy in this context.
- **Option C:** This option is incorrect because, while it has some activity, it is not the treatment of choice for Listeria meningitis, especially in a penicillin-allergic patient.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **TMP-SMX is a critical alternative** for patients with penicillin allergy who develop Listeria infections. Listeria monocytogenes is notably resistant to many cephalosporins and aminoglycosides, making **TMP-SMX a valuable option**. Always consider the patient's allergy history when selecting an antibiotic.

## **Correct Answer:** **D. Trimethoprim-sulfamethoxazole (TMP-SMX)**